ATS 2024 Final Program

Click on the session title to view the speakers

125

MONDAY • MAY 20

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

B16 NOVEL INSIGHTS INTO ASTHMA PATHOGENESIS 9:15 a.m. - 11:15 a.m. Oral Presentations: 9:15 Immunoproteasome Inhibits Airway Type 2 Inflammation in Part Through the Degradation of IL4-Ralpha 9:27 FoxP3+ Regulatory T Cells Require Ccr4 to Execute Suppressive Function and Restrain Allergic Inflammation 9:39 Enose - Derived Response Clusters in Severe Asthmatics Treated With Anti-IL5/5R Biologics 9:51 High Airway TSLP Levels in Asthma Associate With More Severe Disease and Multiple Biomarkers of Type 2 Inflammation 10:03 Methyl-TWAS: A Powerful Method for In Silico Transcriptome-wide Association Studies (TWAS) Using Long-range DNA Methylation 10:15 Single-cell RNA Sequencing Analysis of Blood and Nasal Brushing From Asthma Patients Receiving a Single Dose of SAR443765, A Novel, Bispecific Anti-TSLP/Anti-IL-13 Nanobodyr Molecule Reveals Significant Impact on Multiple Pathological Immune Cell Populations and Downregulation of CCL26 Expression in Epithelial Cell Subpopulations 10:27 Upper Airway Expression of 3 Epithelial and Immune Cell Genes Predicts Responsiveness to Mepolizumab Therapy in Children 10:39 Airway Epithelial Immune Responses in Type 2-Low Pediatric Asthma 10:51 Human Rhinovirus Replication and Interferon Responses by Bronchial Epithelium, and Severe Exacerbation History, Is Associated With IFIH1 Polymorphism rs1990760 in Children With Asthma 11:03 The Genetic Polymorphisms in Leukocyte Immunoglobulin-like Receptor B3 (LILRB3) Gene Are Associated With the Respiratory Diseases in the Population With African American Ancestry Marriott Marquis San Diego Marina Pacific Ballroom 24-26 (Ground Floor, North Tower)

B17 CUTTING EDGE RESEARCH ON DISPARITIES IN PULMONARY AND CRITICAL CARE MEDICINE 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 6D (Upper Level) Oral Presentations: 9:15 A Normal Forced Vital Capacity Does Not Reliably or Equitably Exclude a Restrictive Ventilatory Impairment 9:27 Race-neutral PFTs and Impact on Compensation and Pension Eligibility Within One Veterans Affairs Medical Center 9:39 Interstitial Lung Disease Mortality Disparities Along the United States - Mexico Border, 1999-2020 9:51 Delays in Workup and Treatment of Pulmonary Fibrosis Associated With Limited-English Proficiency Are Improved by Native Language Communication 10:03 “It Can’t Hurt!”: Why Many Patients With Multiple Comorbidities and Limited Life Expectancy Decide to Accept Lung Cancer Screening 10:15 Uptake, Effectiveness, and Acceptability of Routine Screening of Pregnant Migrants for Latent Tuberculosis Infection in Antenatal Care: A Feasibility Study 10:27 Development of a Risk Model to Predict Social Determinants of Health Needs Using Electronic Health Record and Social Vulnerability Index Data With Machine Learning 10:39 Evaluation of Job Lock and Patient Reported Financial Impacts in People With Cystic Fibrosis 10:51 Geographic Variation in Financial Hardship Among Veterans Amid the COVID-19 Pandemic 11:03 Role of Built and Social Environments in Post-COVID Recovery: A Qualitative Study of Patients and Caregivers

ATS 2024 Conference Program • San Diego, CA